cytarabine has been researched along with Gastritis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abu-Sbeih, H; Ali, FS; Curry, JL; Foo, WC; Ge, PS; Luo, W; Neelapu, SS; Okhuysen, PC; Richards, DM; Tang, T; Wang, Y; Westin, JR | 1 |
Eyre, T; Grech, H; King, AJ; Rangarajan, D; Sampson, R | 1 |
2 other study(ies) available for cytarabine and Gastritis
Article | Year |
---|---|
Gastrointestinal Adverse Events Observed After Chimeric Antigen Receptor T-Cell Therapy.
Topics: Adult; Age Distribution; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biopsy, Needle; Cohort Studies; Cytarabine; Daunorubicin; Female; Gastric Mucosa; Gastritis; Gastrointestinal Diseases; Hematologic Neoplasms; Humans; Immunohistochemistry; Immunotherapy, Adoptive; Incidence; Male; Middle Aged; Prognosis; Receptors, Chimeric Antigen; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sex Distribution; Thioguanine | 2019 |
Acute isolated transmural neutropenic gastritis.
Topics: Acute Disease; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Carbazoles; Cytarabine; Daunorubicin; Factor VII Deficiency; Female; Furans; Gastritis; Granulocyte Colony-Stimulating Factor; Humans; Incidental Findings; Leukemia, Myeloid, Acute; Middle Aged; Neutropenia; Recurrence; Tomography, X-Ray Computed; Treatment Outcome | 2012 |